As of June 9, 2025, Pfizer's stock price is $23.39, which is slightly below the day's high of $23.54 and the day's low of $23.35. The trading volume on June 4, 2025, was 24,500,119 shares, which is significantly higher than the average trading volume for Pfizer.

Pfizer has been in the news recently for its continued efforts in the healthcare sector. The company has declared a dividend of $0.43 per share for the quarter ending June 2025, which is a positive signal for investors. Additionally, Pfizer's focus on innovative treatments and vaccines has maintained investor interest despite the challenges in the global market.

Major analysts have been updating their price targets for Pfizer. Some analysts have recommended a "buy" rating with a price target of $31.54, which is 35.1% above the current share price. This indicates a strong potential for growth in the stock.

The 52-week high for Pfizer stock was $31.54, while the 52-week low was $20.92. The average stock price over the last 52 weeks is $26.68. These figures suggest that while Pfizer's stock has experienced some volatility, it remains a stable investment option in the healthcare sector.

Overall, Pfizer's current stock price and trading volume indicate a steady performance. The company's recent dividend declaration and analysts' positive outlook suggest that investors should continue to monitor Pfizer for potential long-term growth opportunities.

For more http://www.quietplease.ai

Stock up on these deals
https://amzn.to/3QFpYIX

This content was created in partnership and with the help of Artificial Intelligence AI